Renata PLC (DSE:RENATA)

Market Cap	58.16B
Revenue (ttm)	39.91B
Net Income (ttm)	2.96B
Shares Out	114.70M
EPS (ttm)	25.78
PE Ratio	19.67
Forward PE	23.26
Dividend	9.20 (1.82%)
Ex-Dividend Date	Oct 22, 2024

Volume	9,736
Average Volume	17,940
Open	507.00
Previous Close	508.30
Day's Range	505.10 - 512.00
52-Week Range	495.00 - 954.90
Beta	0.06
RSI	30.76
Earnings Date	Apr 28, 2025

About Renata

Renata PLC manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh. Its pharmaceutical products include antimicrobials, anti-hypertensive, anti-angina, anti-diabetic, eye-ear and topical preparation, antigout, NSAID, anti-spasmodic, steroid, anti-osteoporotic, anti-allergic, cardiovascular, CNS, hormone, anti-cancer, oxytocic, anti-fibrinolytic, anti-asthma, expectorant, oral rehydration saline, narcotic analgesic, antipyretic/analgesic, antiemetic, anesthetic, antiviral, a...

• Industry: Pharmaceutical Preparations
• Founded: 1972
• Employees: 7,859
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: RENATA

Financial Performance

In 2024, Renata's revenue was 37.71 billion, an increase of 14.37% compared to the previous year's 32.97 billion. Earnings were 3.62 billion, an increase of 54.57%.